Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Insulinoma × Endocrine × Clear all

Phase

Phase 2 15 Phase 1 10 Phase NA 7 Phase 3 3 Phase EARLY_PHASE1 2 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroendocrine Tumors 32 Carcinoma, Neuroendocrine 20 Carcinoma, Non-Small-Cell Lung 12 Small Cell Lung Carcinoma 10 Sarcoma 9 Neoplasms 8 Lung Neoplasms 8 Thyroid Cancer, Papillary 7 Stomach Neoplasms 7 Head and Neck Neoplasms 7 Thyroid Neoplasms 6 Pheochromocytoma 6 Paraganglioma 6 Neoplasm Metastasis 6 Colorectal Neoplasms 6 Thyroid Carcinoma, Anaplastic 5 Ovarian Neoplasms 5 Gastro-enteropancreatic neuroendocrine tumor 5 Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Thyroid Diseases 4 Thoracic Neoplasms 4 Respiratory Tract Neoplasms 4 Respiratory Tract Diseases 4 Neoplasms by Site 4 Multiple Endocrine Neoplasia Type 1 4 Lung Diseases 4 Endocrine System Diseases 4 Endocrine Gland Neoplasms 4 Colonic Neoplasms 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03189953 2021-06-16

GLP-1-AHH

Radboud University Medical Center

Phase 1/2 Completed

Insulinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡